SlideShare a Scribd company logo
Glomerular disorders
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
3 layers of glomerular membrane
• Fenestrated endothelium
• GBM
• Foot process of podocytes
TONY SCARIA 2010
KMC
• Endothelial pore size 70-100nm
• Filtration slit 
TONY SCARIA 2010
KMC
Filtrationslit  20-30nm
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Size of
particle
>8nm cannot pass through GBM
<4nm easily filtered
irrespective of charge
4-8nm
• Negatively charged particles are
repelled
TONY SCARIA 2010
KMC
Endothelium
• Negative charge is d/t podocalyxin
• Fenestrated endothelium
• Pore size 70-100nm
TONY SCARIA 2010
KMC
GBM
• Glomerular basement membranee
• Thickness  350-400nm
• Thin basement membrane  <200nm
• Type IV collagen
• α3 α4 α5
• Electronegativity of GBM Heparin sulphate proteoglycans 
perlecan & agrin
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
• GBM lined inside by
• Endothelium & mesangium
• Outside GBM lined by
• Podocytes
TONY SCARIA 2010
KMC
Jones methylamine silver stain  best stain
for GBM
PAS also may be used to
stain GBM
TONY SCARIA 2010
KMC
Podocytes
TONY SCARIA 2010
KMC
• Podocytes are terminally differentiated  cannot replicate or
regenerate
• Filtration
• b/w 2 podocytes
• 20-30nm
• Electronegativity is d/t podocalyxin (sialoglycoprotein)
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Endothelial filtration barrier
TONY SCARIA 2010
KMC
Mesangium
• Foot process of mesangial cells contain actin
microfilaments
• Mesangial cell help in contraction
TONY SCARIA 2010
KMC
Juxtaglomerular apparatus
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
JGA
• Mesangial cells
• Macula densa of distal tubule
• Granular cells of afferent arteriole
secrete renin
TONY SCARIA 2010
KMC
Tubuloglomerular feedback
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Renin secretion is increased by Renin secretion is decreased by
• Decreased intravascular volume
• Decreased renal perfusion pressure
• Sympathetic stimulation
• PGE2 & PGI2
TONY SCARIA 2010
KMC
• Endothelial injury microscopic hematuria
• In post infectious GN
• Injury to GBM  microscopic hematuria + proteinuria
• Alport syndrome
• Injury to mesangial cells  macroscopic hematuria
• IgA nephropathy
• Injury to podocyte  proteinuria
• Membranous ds
• FSGS
• Minimal change ds
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Asymptomatic Macroscopic
hematuria
Nephrotis
syndrome
• Asymptomati
c
• Proteinuria
• Microscopic
Hematuria
• Proteinuria
(>3.5gm/24h
r)
• Hypoalbumin
emia
• Edema
• Hypercholest
rolemia
• Lipiduria
Renal biopsy is
required
Renal biopsy is
required
FSGS
Membranous
nephropathy
IgA nephropathy TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Proteinuria types
•
Overflow
proteinuria
Tubular proteinuria Glomerular
proteinuria
Functional Orthostatic Persistent non
nephrotic
In multiple myeloma • Anxiety
• Stress
Overcomes ability of
proximal tubule to
reabsorb light chains
• <2g/day
• Mostly beta 2
macroglobulin is
lost
• >2g/day
• Mostly albumin
is lost
• Loss of protein
150-500mg
• Proteinurial
alone in standing
position
• <1g/day
• No proteinuria in
lying down
position  early
morning sample
–ve
TONY SCARIA 2010
KMC
Nephrotic syndrome
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Nephrotic syndrome
• Characterised by
• Albuminuria(proteinuria)
• Hypoalbuminemia
• Edema
• Hyperlipidemia
• lipiduria.
• Hypercoagulability
TONY SCARIA 2010
KMC
Protein decreased Effect
Albumin Edema
Transferrin Iron resistant microcytic hypochromic anemia
Thyroxine binding globulin Decreased thyroxine level
Cholecalciferol binding protein Hypocalcemia
Ceruloplasmin
AT III Increased thrombus formation
Nephrotic syndrome is characteristically associated with
increased fibrinogen levels (Hyper fibrinogenemia)d/t
increased hepatic synthesisTONY SCARIA 2010
KMC
muerhrckes line in hypoalbuminemia
TONY SCARIA 2010
KMC
Nephrotic edema
TONY SCARIA 2010
KMC
Causes of NS
Systemic causes Glomerular disease
• Diabetes mellitus (most common cause),
SLE, Amyloidosis
• Drugs: Gold, penicillamine probenecid ,
street heroin, captopril, NSAIDs
• Infections: Bacterial endocarditis ,
hepatitis B , shunt infections, syphilis,
malaria
• Malignancy: Hodgkin’s and other
lymphomas leukemia, carcinoma of
breast and GI tract
• Allergic reactions
• 1. Minimal change disease (90% in
children and 15% in adults)
• 2. Membranous (40% in adults)
• 3. Focal segmental glomerulosclerosis
• 4. Membranoproliferative GN
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Mc cause of nephrotic syndrome
In children Minimal change disease
In adults focal segmental glomerulosclerosis (FSGS)
In old age Membranous GN
Over all MC cause FSGS
TONY SCARIA 2010
KMC
Minimal change ds
• Lipoid nephrosis
• Most common cause of NS in children (2-7yrs)
• Selective proteinuria of albumin  frothy urine
• Edema
• Hypertension not a feature
TONY SCARIA 2010
KMC
Causes of minimal change ds
• Idiopathic
• Drugs – NSAID, rifampicin, IFN – alpha
• Malignancies  Hodgkin’s disease
• HIV
• Routine immunisation
• Respiratory infection
• Atopic disorders
• Allergy
• insect sting TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
MINIMAL CHANGE DS
• No abnormality on electron
microscopy
• Elctron microscopy 
obliteration & fusion of foot
process
• Immunofluroscopy no
immune deposits
• Serum compliment –> normal
level
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
• Clinical Features-
• Patient usually presents with insidious onset of generalized edema,
without a decrease in urine output.
• Patient may complain of passing frothy urine due to presence of protein.
• Nephrotic syndrome is associated with = ↑LDL, ↑Tg, ↓HDL
• Patient of nephrotic syndrome can develop spontaneous peripheral arterial or
venous thrombosis
• Increased susceptibility to infection
•  MC cause is streptococcus pneumoniae followed by E coli
TONY SCARIA 2010
KMC
Minimal change ds not associated with
• HTN
• Microhematuria
• AKI
TONY SCARIA 2010
KMC
Proteinuria in GN
• Effacement of foot process (Earlier called fusion of foot process) is
believed to play an important role in causes proteinuria in MCD.
• Proteinuria occur due to.
• 1. Loss of negative charge (Loss of polyanions)
• 2. Disruption of components of slit diaphragm (Demonstrated in congenital
nephrotic syndrome of the Finnish type)
• 3. Loss of actin cytoskeleton
TONY SCARIA 2010
KMC
Urine in NS
• Lipoid cast (d/t lipiduria)
• Hyaline cast
• NO RBC
• Mlatese cross appearance 
lipiduria
TONY SCARIA 2010
KMC
Hypercoagulability in NS
• Spontaneous thrombosis of limb arteries
• Renal vein thrombosis
TONY SCARIA 2010
KMC
Renal vein thrombosis in NS
• More common in membranous nephropathy
• Present with abdominal pain & haematuria
• Renal vein thrombosis due to
• 1. Increase Fibrinogen
• 2. Increase Lipoproteins
• 3. Reduced antithrombin III &protein C
TONY SCARIA 2010
KMC
Renal vein thrombosis
• Trauma
• Extrinsic compression (lymph nodes, aortic aneurysm, tumor)
• Invasion by renal cell carcinoma
• Dehydration (infants)
• Nephrotic syndrome specially membranous GN (adults)
• Pregnancy or oral contraceptives
TONY SCARIA 2010
KMC
• Common Renal pathologies causing Renal Vein Thrombosis
• Membranous Glomerulonephritis (strongest association)
• Membranoproliferative Glomerulonephritis
• Amyloidosis
• Lupus Nephritis
TONY SCARIA 2010
KMC
Congenital NS
• With in first 3 months
• Steroid resistant
TONY SCARIA 2010
KMC
Congenital NS
Gene Protein Disease Inheritance
NPHS1 Nephrin in slit
diaphragm
Nephrotic syndrome
of finnish type
(FSGS)
AR inheritance 19p13.1
NPHS2 Podocin in slit
diaphragm
Steroid resistant
NS(FSGS)
AR 1q25
FSGS1 α actinin 4 FSGS Dominant 19p13
TONY SCARIA 2010
KMC
Complications of NS
• Infections (pneumococcal peritonitis) MC complication
• Hypercholesterolemia (atherosclerosis, xanthomata)
• 'The lipid profile in Nephrotic syndrome is characterized by elevations in total
plasma cholesterol, VLDL and LDL and often (increases in later stages) triglyceride &
reduced HDL.
• Venous thrombosis and pulmonary embolism (urinary loss of antithrombin
III, low plasma volume, increased Fibrinogen)
• Hypovolemia and renal failure
• Loss of specific binding proteins, e.g. transferrin, thyroid binding globulin.TONY SCARIA 2010
KMC
Indications for renal biopy in NS
• To r/o causes other than MCNS
• Age <1yr or > 8 yrs
• Adult is less likely to be MCNS  mandatory renal biopsy
• Gross hematuria
• HTn
• Renal insufficiency
• Low C3
• Initial steroid resistance
TONY SCARIA 2010
KMC
Rx
• Salt restriction < 2g/day
• Protein  1g/kg/day
• Target BP
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Minimal change ds progressing to AKI
• Generally no features of AKI
• But can occur if
• Severe hypoalbuminemia pre renal failure
• RVT
TONY SCARIA 2010
KMC
Membranous GN
• MC of NS in elderly
TONY SCARIA 2010
KMC
Membranous GN
• It is characterized morphologically by the presence of subepithelial
immunoglobulin-containing deposits along the GBM.
• Early in the disease, the glomeruli may appear normal by light
microscopy, but well-developed cases show diffuse thickening of the
capillary wall
TONY SCARIA 2010
KMC
Membranous GN
TONY SCARIA 2010
KMC
Diffuse granular staining of basement
membrane with Ig & complement
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Electron microscopy
• Subepithelial GBM
deposits
• Eoimembranous deposits
• Deposition of immune
complexes b/w BM &
podocytes
• effacement of podocytes
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Pathogenesis of membranous GN
Primary membranous GN Secondary membranous GN
autoantibodies that cross-react with antigens
expressed by podocytes
Secondary to other systemic ds
Rat model Human model
Ab against megalin Ag
of rat podocyte 
heymann nephritis
Ab against PLA2 receptor of
human podocyte
TONY SCARIA 2010
KMC
Primary membranous nephropathy
TONY SCARIA 2010
KMC
Causes of secondary GN
Idiopathic (majority) infection: Neoplasia Drugs: Miscellaneous Autoimmunse ds
• Hepatitis B and C
• secondary and
congenital syphilis
• malaria,
• schistosomiasis,
• leprosy,
• hydatid disease,
• filariasis,
• enterococcal
endocarditis
• Carcinoma of the
breast, lung,
colon, stomach,
and esophagus;
• melanoma;
• renal cell
carcinoma;
• neuroblastoma;
• carotid body
tumor
• Gold,
• penicillamine,
• captopril,
• NSAIDs,
• probenecid,
• trimethadione,
• chlormethiazole,
• mercury
1. ​Sarcoidosis
2. Diabetes mellitus
3. Sickle cell disease
4. Crohn’s disease
5. Guillain – Barre
syndrome
• SLE,
• rheumatoid
disease,
• Sjorgren’s
syndrome,
Hashimoto’s
disease,Graves’
disease, mixed
connective tissue
disease, primary
biliary cirrhosis,
• ankylosing
spondylitis,
• dermatitis
herpetiformis,
bullous
pemphigoid,
• myasthenia gravis
TONY SCARIA 2010
KMC
CF of membranous GN
• Massive proteinuria
• Hematuria & HTn in 15-35 % cases
• Patients present with edema, nephrotic proteinuria and high BP.
• Renal insufficiency and abnormal urine sediment may develop later.
• Renal vein thrombosis is common.
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Focal segmental glomerulosclerosis
• MC overall cause of NS
• MC in adults
TONY SCARIA 2010
KMC
FSGS
• sclerosis affecting some but not all glomeruli (focal involvement) and
involving only segments of each affected glomerulus (segmental
involvement)
TONY SCARIA 2010
KMC
FSGS
TONY SCARIA 2010
KMC
Focal & segmental involvement of glomeruli
in FSGS
TONY SCARIA 2010
KMC
Pathogenesis of FSGS
• injury to the podocytes initiating event of primary FSGS
• Lymphocyte produced factor increasing permeability
• The deposition of hyaline masses in the glomeruli represents the
entrapment of plasma proteins and lipids in foci of injury where
sclerosis develops.
• IgM and complement proteins commonly seen in the lesion are also
believed to result from nonspecifc entrapment in damaged glomeruli
TONY SCARIA 2010
KMC
Causes of FSGS
• Idiopathic (majority)
• In associated with systemic diseases or drugs:
• 1. HIV infection
• 2. Diabetes mellitus
• As consequence of sustained glomerular capillary hypertension
• Congenital oligo nephropathies
• Unilateral renal agenesis
• Reflux nephropathy
• Glomerulonephritis or tubulointerstitial nephritis
• Sickle cell nephropathy
• Heroin use
• Congenital Nephrotic syndrome
• NPH1
• NPH2
• FSGS1  autosomal dominant FSGS
• Mutation in TRPC6
TONY SCARIA 2010
KMC
Mutated TRPC6  adult onset type FSGS
(increasing Ca2+ influx)
TONY SCARIA 2010
KMC
APOL1 gene mutation in FSGS
• apolipoprotein L1 gene (APOL1) on chromosome 22 appears to be
strongly associated with an increased risk of FSGS and renal failure
TONY SCARIA 2010
KMC
Histologic variants of FSGS
Collapsing
variant
• Worse
prognosis
Glomerular tip
variant
• Best
prognosis
Perihilar
variant
Cellular
variant
TONY SCARIA 2010
KMC
Variants of FSGS
TONY SCARIA 2010
KMC
• Light microscopy
• increased mesangial matrix,
obliterated capillary lumina, and
deposition of hyaline masses
(hyalinosis) and lipid droplets.
• Electron microscopy
• podocytes exhibit effacement of foot
processes, as in minimal change
disease
• IF
• Nonspecific trapping of Ig (especially
IgM) & complement(C3) TONY SCARIA 2010
KMC
Collapsing variant of FSGS
• Worst prognosis
• It is characterized by collapse of
the glomerular tuft and podocyte
hyperplasia
• associated with HIV infection,
drug-induced toxicities, and some
microvascular injuries
TONY SCARIA 2010
KMC
• CF:
• Proteinuria is present and is usually nonselective.
• Hypertension, reduced GFR(arteriolar obliteration by sclerosis),
abnormal tubular function and abnormal urinary sediments
(leukocyturia, hematuria) are seen.
• Hyperlipidemia is severe in cases with focal sclerosis.
TONY SCARIA 2010
KMC
Relfux nephropathy & FSGS
• FSGS may develop following acquired loss of nephrons from reflux
nephropathy
• Association of reflux nephropathy and proteinuria suggest an
irreversible glomerular lesion most commonly FSGS
TONY SCARIA 2010
KMC
Podocytopathies
• a/w podocyte injury
• Minimal change ds
• Membranous GN
• FSGS
TONY SCARIA 2010
KMC
Membranoproliferative GN
• Immune mediated injury
TONY SCARIA 2010
KMC
Membrano proliferative GN
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Type 1 (MC SUBTYPE) Type II Type III
Sub endothelial electron dense deposits lamina densa and the subendothelial
space of the GBM
are transformed into an irregular, ribbon-
like, extremely
electron-dense structure, resulting from
the deposition of
material of unknown composition
DENSE DEPOSIT DISEASE
Double contours of GBM & subendothelial
deposits subepithelial deposits
Subendothelial deposits of occasionally
granular epithelial & mesangial Ig
Intramembranous deposition
Activation of classical & alternate pathway Activation of alternate pathway
• Idiopathic
• Bacterial endocarditis
• SLE
• Hepatitis C
• Mixed cryoglobulinemia
• Hepatitis B
• Cancer: Lung, breast, and ovary
(germinal)
• Idiopathic
• C3 nephritic factor–associated
• Partial lipodystrophy
• Idiopathic
• Complement FACTOR deficiency
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Type I MPGN
TONY SCARIA 2010
KMC
Type I MPGN
• discrete subendothelial electron-dense deposits
• C3 is deposited in an irregular granular pattern, and IgG and early
complement components (C1q and C4) often are also present,
indicative of an immune complex pathogenesis
TONY SCARIA 2010
KMC
Type II MPGN
TONY SCARIA 2010
KMC
Type II MPGN
• d/t activation of alternate
complement pathway
• They have C3 nephritic
factor (C3NeF)
• Stabilises C3 convertase 
enhancing C3 activation 
hypocomplementemia
TONY SCARIA 2010
KMC
Type III MPGN
• Intramembranous + subendothelial + subepithelial deposit
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Light microscopy
• Thickened capillary loops
• Glomerular cell proliferation
• Lobular appearance of glomeruli
• d/t mesngial proliferation
• Duplication of basement
membrane
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Subendothelial deposits
TONY SCARIA 2010
KMC
Dense intramembranous
deposits
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
• Compliment levels are normal in
• 1. Minimal change GN
• 2. Membranous GN
• 3. FSGS
Decreased compliment level in MPGN
TONY SCARIA 2010
KMC
Nephritic syndrome
TONY SCARIA 2010
KMC
Nephritic syndrome
• a/c glomerulonephritis
• Hypertension,
• Hematuria with red cell cast  high coloured urine
• non nephrotic Proteinuria
• Normal albumin level
• Azotemia & Oliguria a/w AKI
• RBC cast are present in the urine.
TONY SCARIA 2010
KMC
nephritic syndromw
Mc cause in
Children Post streptococcal GN
Adults IgA nephropathy
Overall IgA nephropathy
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
a/c proliferative GN
Post infectious GN
TONY SCARIA 2010
KMC
• Postinfectious glomerulonephritis
• occur as a sequela of disease caused by bacteria, viruses, fungi, protozoa,
and helminths
• Post streptococcal GN most common cause of GN in childhood
TONY SCARIA 2010
KMC
Nephritis develops 1–3 weeks after pharyngeal (more common in
winter) or cutaneous infection with (more common in summer)
‘nephritogenic’ strains of group A beta – hemolytic streptococci
Group A beta haemolytic
streptococci
TONY SCARIA 2010
KMC
Cutaneous streptococcal infection
TONY SCARIA 2010
KMC
Pathogenesis of PSGN
• immune complex disease
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
• Light microscopy
• diffuse  increased cellularity of the glomerular tufts that affects nearly all
glomeruli
• Electron microscopy
• deposited immune complexes arrayed as subendothelial, intramembranous, or, most
often, subepithelial “humps” nestled against the GBM
• Immunofluorescence studies reveal scattered granular deposits of IgG
and complement within the capillary walls and some mesangial areas,
corresponding to the deposits visualized by electron microscopy.
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
IF deposits  starry sky appaearance in PSGN
TONY SCARIA 2010
KMC
CF of PSGN
• sudden onset of hematuria and edema
TONY SCARIA 2010
KMC
Lab findings
• Hypocomplementemia
• elevated titers of
• antistreptolysin 0,
• antihyaluronidase, and
• anti-deoxyribonuclease B antibodies
• Unfavourable prognostic factors
• Prolonged persistent heavy proteinuria
• Abnormal GFR
TONY SCARIA 2010
KMC
Rx
• Hypertension must be treated aggressively,
• Furosemide or bumetanide is required for the underlying edema-
inducing disease.
• Antibiotic - penicillin.
• Prophylaxis following poststreptococcal glomerulonephritis is not
indicated because recurrences are exceedingly rare.
• Early treatment of pharyngitis does not prevent development of acute GN.
• Immunosuppressive agents or corticosteroids have no therapeutic
role.
• Recurrence is uncommon with PSGNTONY SCARIA 2010
KMC
IgA Nephropathy (Berger’s Disease)
• Most common causes of recurrent microscopic or gross hematuria
• MC of GN world wide
• IgA nephropathy is a type of mesangioproliferative
glomerulonephritis with IgA deposition in the mesangium
• Pathogenesis
• Genetic or acquired defects in immune regulation
• Increased IgA1 secretion (only IgA1 is nephritogenic)
• Decreased clearance of IgA
TONY SCARIA 2010
KMC
Onset of hematuria occurs 1-4 days after
URTI
TONY SCARIA 2010
KMC
Secondary IgA nephropathy
• Celiac ds
• c/c Liver pathology
• HSP
TONY SCARIA 2010
KMC
• Light microscopy
• Mesangial proliferation
• Cresents may be present
• Electron microscopy
• Mesangial deposits of IgA IgG or IgM with C3
• Compliment level remain same
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
IgA nephropathy PSGN
Onset of hematuria after URTI 1-4 days 1-4 weeks
Serum C3 level Normal Transiently decreases for 6-8 weeks
Recurrence Common Rare
Antibody titre Not elevated Elevated ASO titre
TONY SCARIA 2010
KMC
Other causes of mesangioproliferative GN
Mesnagioproliferative GN
• IgA nephropathy
• HSP
Proliferation of mesangial cells and
deposition of IgA in matrix
• Hematuria
• Proteinuria
• Hypertension
TONY SCARIA 2010
KMC
RPGN
TONY SCARIA 2010
KMC
RPGN
• RPGN is defined by 2 criteria
• 1. Presence of epithelial crescents in more than 70% of glomeruli
• 2. Occurrence of rapidly progressive renal failure, End stage disease occurs
within month
• Presents with nephritic syndrome  rapidly progresses to loss of
renal function
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
RPGN
Crescent
TONY SCARIA 2010
KMC
Crescents are features of RPGN
• Crescents are made up of proliferated
parietal epithelial cells fibrin &
leucocyte
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Type I RPGN Type II RPGN Type III RPGN
Anti GBM mediated
Ab against α3 chain of collagen IV
Immune complex mediated Pauci immune
ANCA associated
Most common
IF  linear deposits along
basement membrane
IF granular deposits IF  no deposits
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Type I RPGN Type II RPGN Type III RPGN
• Idiopathic
• Good pastures syndrome
• Idiopathic
• SLE
• Ig A nephropathy
• MPGN
• Cryoglobulinemia
• Post infectious GN
• Idiopathic
• Granulomatosis with polyangitis
• Microscopic polyangitis
• Best prognosis
TONY SCARIA 2010
KMC
Prognosis of RPGN
• The prognosis of RPGN depends upon Number of crescents.
TONY SCARIA 2010
KMC
• Diagnosis
• Renal biopsy
• Rx
• Plasmapheresis & immunosuppression
• In immune complex glomerulonephritis, treatment depends on the
individual causative disorder.
• In pauci-immune deposit disease, treatment involves pulse
methylprednisolone and cyclophosphamide.
TONY SCARIA 2010
KMC
Good pasture syndrome
TONY SCARIA 2010
KMC
Good pasture syndrome
• characterized by formation of Anti GBM antibodies that attack both
pulmonary capillaries and the Glomerulus
• Type II hypersensitivity
TONY SCARIA 2010
KMC
Triad of goodpasture syndrome
• Anti GBM ab
• Directed against Non collagenous domain of type α3 collagen
• Glomerulonephritis (usually crescentic)
• Pulmonary hemorrhage (Hemoptysis may precede nephritis).
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Ab in good pasture syndrome
• Circulating Anti GBM antibodies (lgG): Positive
• ANCA antibodies: Typically Negative (ANCA negative vasculitis)
• ANA antibodies: usually normal
• C3 levels: Usually normal
• Antibodies against Non collagenous Domain (NCL) of a3 chain of
collagen type IV
TONY SCARIA 2010
KMC
CF in good pasture syndrome
• 1. Hemoptysis (Frank)
• 2. Dyspnea
• 3. Hematuria
• 4. Proteinuria
• 5. Edema
TONY SCARIA 2010
KMC
Pathology in good pasture
syndrome
• Diffuse crescentic Glomerulonephritis
• Linear IgG staining along basement
membrane on immunofluorescence
TONY SCARIA 2010
KMC
B/L pulmonary infiltrates are seen on CXR in good pasture syndrome
TONY SCARIA 2010
KMC
• Treatment:
• 1. Plasma exchange may produce remission.
• 2. Prednisolone
• 3. Immunosuppressive therapy
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Alport syndrome
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Alport syndrome
• X linked dominant form (85 %
case)
• Mutation in α chain
• Autosomal forms
• Mutation in α3 or α4 chain
TONY SCARIA 2010
KMC
Eye EAR Kidney
• Anterior lenticonus Sensorineural deafness Hematuria
Proteinuria
Abnormal splitting &
lamination of basement
membrane
TONY SCARIA 2010
KMC
ANTERIOR LENTICONUS IN ALPORT
SYNDROME
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
GBM splitting & lamination  basket weave
appearance
TONY SCARIA 2010
KMC
Thin basement membrane
disease
TONY SCARIA 2010
KMC
Thin basement membrane ds
• Benign familial hematuria
• Asymptomatic hematuria
• Thickness of GBM <200nm
TONY SCARIA 2010
KMC
HSP
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
HSP
• MC vasculitis of childhood
• Characterised by leukocytoclastic vasculitis & IgA deposition in small
vessels of skin joints GIT & kidney
• Renal involvement hematuria and proteinuria.
• Serum IgA is normal or raised, platelet count is normal.
TONY SCARIA 2010
KMC
LAB DIAGNOSIS OF HSP
• Antinuclear antibody (ANA) Negative
• Antineutrophil cytoplasmic Negative
• Antibodies (ANCA) Negative
• Complement (C3, C4) Normal
• Cryoglobulins Negative
TONY SCARIA 2010
KMC
CF
• Palpable purpura
• Symmetric mainly on lower extremities & buttocks
• Oligoarticular arthritis & arthralgia
• GI manifestation
• Abdominal pain malena diaarhea
• Renal involvement
• Microscopic hematuria (nephritis)
• Proteinuria
• HTn
• Neurologic
• Seizures
• Cerebral haemorrhage
•
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
American college of rheumatology Pediatric rheumatology European society criteria
2 of the following
 Palpable purpura
 Age at onset <20 yr
 Bowel angina (post prandial abdominal pain/
bloody diarrhea)
 Biopsy  demonstrating intramuscular
granulocytes in arterioles or venules
Palpable purpura (in absence of coagulopathy or
thrombocytopenia
 Abdominal pain
 Arthritis or arthralgia
 Biopsy  IgA deposition
 Renal involvement
• Proteinuria
• Hematuria
• Red cell cast
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Diagnosis
• Leukocytosis thrombocytosis anemia normal platelet count
• Elevated ESR & CRP
• Serum IgA elevated
• Serum albumin levels may be low
• Occult blood
TONY SCARIA 2010
KMC
Rx of HSP
• Supportive Rx
• Prednisolone 1mg/kg/day for 1-2 weeks
TONY SCARIA 2010
KMC
c/c glomerulonephritis
TONY SCARIA 2010
KMC
c/c glomerulonephritis
TONY SCARIA 2010
KMC
c/c glomerulonephritis
• poststreptococcal (1% to 2%);  least common chance of progression
• rapidly progressive (crescentic) (90%) most common chance of
progression
• membranous (30% to 50%),
• focal segmental glomerulosclerosis (50% to 80%),
• membranoproliferative GN (50%),
• IgA nephropathy (IgAN, 30% to 50%).
TONY SCARIA 2010
KMC
c/c glomerulonephritis
the cortex is thinned
increase in peripelvic fat
TONY SCARIA 2010
KMC
c/c glomerulonephritis
• arterial and arteriolar sclerosis
• Marked atrophy of associated
tubules, irregular interstitial
fibrosis, and mononuclear
leukocytic infiltration of the
interstitium
• obliteration of glomeruli,
transforming them into acellular
eosinophilic masses,
TONY SCARIA 2010
KMC
Systemic diseases a/w renal
ds
TONY SCARIA 2010
KMC
Diabetic nephropathy
• Most important predictor of diabetic nephropathy is duration of
disease
• 20 yrs prediction of nephropathy
• Type 1  30 -40 %
• Type 2 15-20 %
TONY SCARIA 2010
KMC
Mechanism of diabetic nephropathy
• Nonenzymatic glycosylation of proteins of basement membrane
TONY SCARIA 2010
KMC
• Earliest lab finding in diabetic nephropathy  increase in GFR
• early stages of diabetic nephropathy are characterized by an
increased GFR, increased glomerular capillary pressure, glomerular
hypertrophy, and an increased glomerular filtration area
TONY SCARIA 2010
KMC
Lesions seen in diabetic nephropathy
glomerular lesions renal vascular lesions, principally
arteriolosclerosis
pyelonephritis, including
necrotizing papillitis
• capillary basement membrane
thickening (earliest lesion)
• diffuse mesangial
sclerosis(most common
histologic finding)
• nodular glomerulosclerosis
TONY SCARIA 2010
KMC
Glomerular lesions
Capillary basement membrane
thickening
Diffuse glomerulosclerosis Nodular glomerulosclerosis
• Earliest lesion • diffuse increase in mesangial
matrix along with mesangial cell
proliferation and
• Glomerular lesion made
distinctive by ball-like deposits
of a laminated matrix situated in
the periphery of the glomerulus
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Nodular glomerulosclerosis
• Most specific &
pathognomonic
TONY SCARIA 2010
KMC
Fibrin cap & capsular drop in diabetic
retinopathy
TONY SCARIA 2010
KMC
Hyaline arteriolar sclerosis
• Affecting afferent & efferent arteriole
TONY SCARIA 2010
KMC
Armanni ebstein cells
• In poorly controlled diabetics
• Proximal tubular cells filled glycogen laden
vacuole
TONY SCARIA 2010
KMC
Causes of papillary necrosis
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Papillary necrosis
• DM  commonest cause
• Analgesic nephropathy
• Sickle cell anemia
• c/c alcoholism
• Urinary tract obstruction
• a/c pyelonephritis
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
• Ball-on-tee appearance: Contrast material filling central excavations in the
papilla of the interpolar region gives ball-on-tee appearance.
• Lobster claw sign: Excavation extending from the caliceal fornices produces
the lobster claw deformity.
• Signet ring sign: The necrotic papillary tip may remain within the excavated
calyx, producing the signet ring sign when the calyx is filled with contrast
material.
• Club shaped saccular calyx: Due to sloughed papillaTONY SCARIA 2010
KMC
TONY SCARIA 2010
KMC
Hepatitis C • Cryoglobulinemic glomerulonephritis
• Membranous glomerulonephritis (MGN)
• Membrano prolferative glomerulo
nephritis(MPGN)
Hepatitis B • In children  MGN
• In adults  MPGN
• Over all  MGN
Toxoplasmosis • MPGN
Syphilis
Schistosomiasis
• MGN
Leprosy • Secondary amyloidosis
• Mesangiocapilalry GN
• MPGN1
• Membranous GN
Malaria • Plasmodium malaria  NS
• Plasmodium falciparum  renal failure
TONY SCARIA 2010
KMC
Essential mixed cryoglobulinemia
• Cold precipitable monoclonal or polyclonal immunoglobulins
• It causes cutaneous vasculitis synovitis palpable purpura
• It causes proliferative GN most commonly MPGN type 1
• a/w hepatitis C
• Hypocomplimentinemia
TONY SCARIA 2010
KMC
Fibronectin nephropathy
• Autosomal dominant
• d/t accumaltion of plasma fibronectin
• Presents with Massive proteinuria
TONY SCARIA 2010
KMC
Mesangial
fibronectin
•Cellular
fibrinopectin
•Nonpathogenic
Liver fibronectin
•Produced by
hepatocytes
•Pathogenic
TONY SCARIA 2010
KMC
Morphology
• Light microscopy
• Glomerular enlargement & lobulation d/t mesangial proliferation & mesangial
deposits
• PAS & trichrome positive
• Renal tubules interstitium blood vessels are not affected
• Immunofurescence
• No immunoglobulin & compliment deposits are seen
• Electron microscopy
• Mesangial & subendothelial deposits
TONY SCARIA 2010
KMC

More Related Content

What's hot

WHO GIT RECENT UPDATES
WHO GIT RECENT UPDATESWHO GIT RECENT UPDATES
WHO GIT RECENT UPDATES
Argha Baruah
 
Recent Advances:Hepatocellular Nodules
Recent Advances:Hepatocellular NodulesRecent Advances:Hepatocellular Nodules
Recent Advances:Hepatocellular Nodules
Dr Niharika Singh
 
Minimal residual disease
Minimal residual diseaseMinimal residual disease
Minimal residual disease
Appy Akshay Agarwal
 
The bethesda system for reporting thyroid cytopathology
The bethesda system for reporting thyroid cytopathology The bethesda system for reporting thyroid cytopathology
The bethesda system for reporting thyroid cytopathology
dhanya89
 
Interpretation of endoscopic intestinal biopsy
Interpretation of endoscopic intestinal biopsyInterpretation of endoscopic intestinal biopsy
Interpretation of endoscopic intestinal biopsy
Appy Akshay Agarwal
 
Non hodgkin lymphoma
Non hodgkin lymphomaNon hodgkin lymphoma
Non hodgkin lymphoma
tashagarwal
 
Fnac of salivary gland tumour
Fnac of salivary gland tumourFnac of salivary gland tumour
Fnac of salivary gland tumour
aghara mahesh
 
Lymphoma spillover.pptx
Lymphoma spillover.pptxLymphoma spillover.pptx
Lymphoma spillover.pptx
Tamil Mahizhenthi
 
IHC in breast pathology
IHC in breast pathologyIHC in breast pathology
IHC in breast pathology
namrathrs87
 
Plasma cell dyscrasias
Plasma cell dyscrasias Plasma cell dyscrasias
Plasma cell dyscrasias
Prince Lokwani
 
Breast pathology i march 15. 2015
Breast pathology i march 15. 2015Breast pathology i march 15. 2015
Breast pathology i march 15. 2015
eliasmawla
 
Cystic diseases of kidney
Cystic diseases of kidney Cystic diseases of kidney
Cystic diseases of kidney
Usman Shams
 
Interpretation of endoscopic gastrointestinal biopsy
Interpretation of endoscopic gastrointestinal biopsyInterpretation of endoscopic gastrointestinal biopsy
Interpretation of endoscopic gastrointestinal biopsy
Appy Akshay Agarwal
 
Mimickers of prostatic carcinoma
Mimickers of prostatic carcinomaMimickers of prostatic carcinoma
Mimickers of prostatic carcinoma
Dr Nidhi Rai Gupta
 
Non hodgkin Lymphoma
Non hodgkin LymphomaNon hodgkin Lymphoma
Non hodgkin LymphomaImad Zafar
 
The bethesda system for reporting thyroid cytopathology
The bethesda system for reporting thyroid cytopathologyThe bethesda system for reporting thyroid cytopathology
The bethesda system for reporting thyroid cytopathology
Indira Shastry
 
Acute leukemia
Acute leukemia Acute leukemia
Acute leukemia
anil kumar g
 
Diagnostic approach to pediatric malignant small round cell
Diagnostic approach to pediatric malignant small round cellDiagnostic approach to pediatric malignant small round cell
Diagnostic approach to pediatric malignant small round cell
Sivaranjini N
 
Renal biopsy interpretation
Renal biopsy interpretationRenal biopsy interpretation
Renal biopsy interpretation
Revathi Krishnmaurthy
 

What's hot (20)

WHO GIT RECENT UPDATES
WHO GIT RECENT UPDATESWHO GIT RECENT UPDATES
WHO GIT RECENT UPDATES
 
Recent Advances:Hepatocellular Nodules
Recent Advances:Hepatocellular NodulesRecent Advances:Hepatocellular Nodules
Recent Advances:Hepatocellular Nodules
 
Minimal residual disease
Minimal residual diseaseMinimal residual disease
Minimal residual disease
 
The bethesda system for reporting thyroid cytopathology
The bethesda system for reporting thyroid cytopathology The bethesda system for reporting thyroid cytopathology
The bethesda system for reporting thyroid cytopathology
 
Interpretation of endoscopic intestinal biopsy
Interpretation of endoscopic intestinal biopsyInterpretation of endoscopic intestinal biopsy
Interpretation of endoscopic intestinal biopsy
 
Non hodgkin lymphoma
Non hodgkin lymphomaNon hodgkin lymphoma
Non hodgkin lymphoma
 
Fnac of salivary gland tumour
Fnac of salivary gland tumourFnac of salivary gland tumour
Fnac of salivary gland tumour
 
Lymphoma spillover.pptx
Lymphoma spillover.pptxLymphoma spillover.pptx
Lymphoma spillover.pptx
 
IHC in breast pathology
IHC in breast pathologyIHC in breast pathology
IHC in breast pathology
 
Plasma cell dyscrasias
Plasma cell dyscrasias Plasma cell dyscrasias
Plasma cell dyscrasias
 
Breast pathology i march 15. 2015
Breast pathology i march 15. 2015Breast pathology i march 15. 2015
Breast pathology i march 15. 2015
 
Cystic diseases of kidney
Cystic diseases of kidney Cystic diseases of kidney
Cystic diseases of kidney
 
Interpretation of endoscopic gastrointestinal biopsy
Interpretation of endoscopic gastrointestinal biopsyInterpretation of endoscopic gastrointestinal biopsy
Interpretation of endoscopic gastrointestinal biopsy
 
Mimickers of prostatic carcinoma
Mimickers of prostatic carcinomaMimickers of prostatic carcinoma
Mimickers of prostatic carcinoma
 
Glomerular diseases
Glomerular diseases Glomerular diseases
Glomerular diseases
 
Non hodgkin Lymphoma
Non hodgkin LymphomaNon hodgkin Lymphoma
Non hodgkin Lymphoma
 
The bethesda system for reporting thyroid cytopathology
The bethesda system for reporting thyroid cytopathologyThe bethesda system for reporting thyroid cytopathology
The bethesda system for reporting thyroid cytopathology
 
Acute leukemia
Acute leukemia Acute leukemia
Acute leukemia
 
Diagnostic approach to pediatric malignant small round cell
Diagnostic approach to pediatric malignant small round cellDiagnostic approach to pediatric malignant small round cell
Diagnostic approach to pediatric malignant small round cell
 
Renal biopsy interpretation
Renal biopsy interpretationRenal biopsy interpretation
Renal biopsy interpretation
 

Similar to Glomerular disorders OF KIDNEY REVISION NOTES

GASTRO INTESTINAL TRACT MEDICINE REVISION NOTES
GASTRO INTESTINAL TRACT MEDICINE REVISION NOTESGASTRO INTESTINAL TRACT MEDICINE REVISION NOTES
GASTRO INTESTINAL TRACT MEDICINE REVISION NOTES
TONY SCARIA
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
Muni Venkatesh
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
Muni Venkatesh
 
Leukemia and lymphoma PATHOLOGY REVISION NOTES
Leukemia and lymphoma PATHOLOGY REVISION NOTES Leukemia and lymphoma PATHOLOGY REVISION NOTES
Leukemia and lymphoma PATHOLOGY REVISION NOTES
TONY SCARIA
 
Parathyroid gland REVISION NOTES
Parathyroid gland REVISION NOTES Parathyroid gland REVISION NOTES
Parathyroid gland REVISION NOTES
TONY SCARIA
 
Retinoblastoma revision notes
Retinoblastoma revision notes Retinoblastoma revision notes
Retinoblastoma revision notes
TONY SCARIA
 
CHILDHOOD MALIGNANCIES REVISION NOTES
CHILDHOOD MALIGNANCIES REVISION NOTESCHILDHOOD MALIGNANCIES REVISION NOTES
CHILDHOOD MALIGNANCIES REVISION NOTES
TONY SCARIA
 
Systemic diseases associated with renal disease
Systemic diseases associated with renal diseaseSystemic diseases associated with renal disease
Systemic diseases associated with renal disease
TONY SCARIA
 
Approach to Pancytopenia with cases.pptx
Approach to Pancytopenia with cases.pptxApproach to Pancytopenia with cases.pptx
Approach to Pancytopenia with cases.pptx
YogeetaTanty1
 
Tubular disorders of kidney REVISION NOTES
Tubular disorders of kidney REVISION NOTESTubular disorders of kidney REVISION NOTES
Tubular disorders of kidney REVISION NOTES
TONY SCARIA
 
Diseases of the kidney
Diseases of the kidneyDiseases of the kidney
Diseases of the kidney
Dr. Varughese George
 
Hepatobiliary system radiology revision notes
Hepatobiliary system radiology revision notesHepatobiliary system radiology revision notes
Hepatobiliary system radiology revision notes
TONY SCARIA
 
SPIROCHAETE REVISION NOTES MICROBIOLOGY
SPIROCHAETE REVISION NOTES MICROBIOLOGYSPIROCHAETE REVISION NOTES MICROBIOLOGY
SPIROCHAETE REVISION NOTES MICROBIOLOGY
TONY SCARIA
 
Multiple myeloma
Multiple myelomaMultiple myeloma
Multiple myeloma
Kiran Bikkad
 
Dm nephropathy
Dm nephropathyDm nephropathy
Dm nephropathy
chindo mallum
 
Hematology revision notes pathology
Hematology revision notes pathology Hematology revision notes pathology
Hematology revision notes pathology
TONY SCARIA
 
Rheumatology revison notes
Rheumatology revison notes Rheumatology revison notes
Rheumatology revison notes
TONY SCARIA
 
pathology of DM nephropathy.pptx
pathology of DM nephropathy.pptxpathology of DM nephropathy.pptx
pathology of DM nephropathy.pptx
Rose635887
 
The pathogenesis of liver cirrhosis and fibrosis
The pathogenesis of liver cirrhosis and fibrosisThe pathogenesis of liver cirrhosis and fibrosis
The pathogenesis of liver cirrhosis and fibrosis
AbbaZarami Bukar
 
Multiple myeloma final 2018 updated
Multiple myeloma final 2018 updatedMultiple myeloma final 2018 updated
Multiple myeloma final 2018 updated
AmrinderSingh248
 

Similar to Glomerular disorders OF KIDNEY REVISION NOTES (20)

GASTRO INTESTINAL TRACT MEDICINE REVISION NOTES
GASTRO INTESTINAL TRACT MEDICINE REVISION NOTESGASTRO INTESTINAL TRACT MEDICINE REVISION NOTES
GASTRO INTESTINAL TRACT MEDICINE REVISION NOTES
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
 
Leukemia and lymphoma PATHOLOGY REVISION NOTES
Leukemia and lymphoma PATHOLOGY REVISION NOTES Leukemia and lymphoma PATHOLOGY REVISION NOTES
Leukemia and lymphoma PATHOLOGY REVISION NOTES
 
Parathyroid gland REVISION NOTES
Parathyroid gland REVISION NOTES Parathyroid gland REVISION NOTES
Parathyroid gland REVISION NOTES
 
Retinoblastoma revision notes
Retinoblastoma revision notes Retinoblastoma revision notes
Retinoblastoma revision notes
 
CHILDHOOD MALIGNANCIES REVISION NOTES
CHILDHOOD MALIGNANCIES REVISION NOTESCHILDHOOD MALIGNANCIES REVISION NOTES
CHILDHOOD MALIGNANCIES REVISION NOTES
 
Systemic diseases associated with renal disease
Systemic diseases associated with renal diseaseSystemic diseases associated with renal disease
Systemic diseases associated with renal disease
 
Approach to Pancytopenia with cases.pptx
Approach to Pancytopenia with cases.pptxApproach to Pancytopenia with cases.pptx
Approach to Pancytopenia with cases.pptx
 
Tubular disorders of kidney REVISION NOTES
Tubular disorders of kidney REVISION NOTESTubular disorders of kidney REVISION NOTES
Tubular disorders of kidney REVISION NOTES
 
Diseases of the kidney
Diseases of the kidneyDiseases of the kidney
Diseases of the kidney
 
Hepatobiliary system radiology revision notes
Hepatobiliary system radiology revision notesHepatobiliary system radiology revision notes
Hepatobiliary system radiology revision notes
 
SPIROCHAETE REVISION NOTES MICROBIOLOGY
SPIROCHAETE REVISION NOTES MICROBIOLOGYSPIROCHAETE REVISION NOTES MICROBIOLOGY
SPIROCHAETE REVISION NOTES MICROBIOLOGY
 
Multiple myeloma
Multiple myelomaMultiple myeloma
Multiple myeloma
 
Dm nephropathy
Dm nephropathyDm nephropathy
Dm nephropathy
 
Hematology revision notes pathology
Hematology revision notes pathology Hematology revision notes pathology
Hematology revision notes pathology
 
Rheumatology revison notes
Rheumatology revison notes Rheumatology revison notes
Rheumatology revison notes
 
pathology of DM nephropathy.pptx
pathology of DM nephropathy.pptxpathology of DM nephropathy.pptx
pathology of DM nephropathy.pptx
 
The pathogenesis of liver cirrhosis and fibrosis
The pathogenesis of liver cirrhosis and fibrosisThe pathogenesis of liver cirrhosis and fibrosis
The pathogenesis of liver cirrhosis and fibrosis
 
Multiple myeloma final 2018 updated
Multiple myeloma final 2018 updatedMultiple myeloma final 2018 updated
Multiple myeloma final 2018 updated
 

More from TONY SCARIA

Mucormycosis
MucormycosisMucormycosis
Mucormycosis
TONY SCARIA
 
Phosphorus metabolism
Phosphorus metabolism Phosphorus metabolism
Phosphorus metabolism
TONY SCARIA
 
cbc Histogram
cbc Histogramcbc Histogram
cbc Histogram
TONY SCARIA
 
Osteoporosis clinical features and management
Osteoporosis clinical features and management Osteoporosis clinical features and management
Osteoporosis clinical features and management
TONY SCARIA
 
Calcium METABOLISM
Calcium METABOLISM Calcium METABOLISM
Calcium METABOLISM
TONY SCARIA
 
Magnesium metabolism
Magnesium metabolism Magnesium metabolism
Magnesium metabolism
TONY SCARIA
 
Special senses physiology revison topics
Special senses physiology revison topics Special senses physiology revison topics
Special senses physiology revison topics
TONY SCARIA
 
CSF PHYSIOLOGY ANALYSIS NORMAL AND DISEASE
CSF PHYSIOLOGY ANALYSIS NORMAL AND DISEASE CSF PHYSIOLOGY ANALYSIS NORMAL AND DISEASE
CSF PHYSIOLOGY ANALYSIS NORMAL AND DISEASE
TONY SCARIA
 
Plantar reflex
Plantar reflexPlantar reflex
Plantar reflex
TONY SCARIA
 
Dna viruses
Dna virusesDna viruses
Dna viruses
TONY SCARIA
 
Deep neck space infection ENT REVISION NOTES
Deep neck space infection ENT REVISION NOTES Deep neck space infection ENT REVISION NOTES
Deep neck space infection ENT REVISION NOTES
TONY SCARIA
 
Antirheumatic drugs &amp; anti gout drugs PHARMACOLOGY REVISION NOTES
Antirheumatic drugs &amp; anti gout drugs PHARMACOLOGY REVISION NOTES Antirheumatic drugs &amp; anti gout drugs PHARMACOLOGY REVISION NOTES
Antirheumatic drugs &amp; anti gout drugs PHARMACOLOGY REVISION NOTES
TONY SCARIA
 
Trauma to eye REVISION NOTES
Trauma to eye REVISION NOTES Trauma to eye REVISION NOTES
Trauma to eye REVISION NOTES
TONY SCARIA
 
Orbit OPHTHALMOLOGY REVISION NOTES
Orbit OPHTHALMOLOGY REVISION NOTES Orbit OPHTHALMOLOGY REVISION NOTES
Orbit OPHTHALMOLOGY REVISION NOTES
TONY SCARIA
 
Vision 2020 REVISION NOTES
Vision 2020 REVISION NOTES Vision 2020 REVISION NOTES
Vision 2020 REVISION NOTES
TONY SCARIA
 
Cataract revisionnotes ophthalmology
Cataract revisionnotes ophthalmology  Cataract revisionnotes ophthalmology
Cataract revisionnotes ophthalmology
TONY SCARIA
 
Uvea ophthalmology revision notes
Uvea ophthalmology revision notesUvea ophthalmology revision notes
Uvea ophthalmology revision notes
TONY SCARIA
 
Genetics pathology revision notes
Genetics pathology revision notes Genetics pathology revision notes
Genetics pathology revision notes
TONY SCARIA
 
Cell injury pathology revision notes
Cell injury pathology revision notes Cell injury pathology revision notes
Cell injury pathology revision notes
TONY SCARIA
 
Morphology of bacteria revision notes microbiology
Morphology of bacteria revision notes microbiologyMorphology of bacteria revision notes microbiology
Morphology of bacteria revision notes microbiology
TONY SCARIA
 

More from TONY SCARIA (20)

Mucormycosis
MucormycosisMucormycosis
Mucormycosis
 
Phosphorus metabolism
Phosphorus metabolism Phosphorus metabolism
Phosphorus metabolism
 
cbc Histogram
cbc Histogramcbc Histogram
cbc Histogram
 
Osteoporosis clinical features and management
Osteoporosis clinical features and management Osteoporosis clinical features and management
Osteoporosis clinical features and management
 
Calcium METABOLISM
Calcium METABOLISM Calcium METABOLISM
Calcium METABOLISM
 
Magnesium metabolism
Magnesium metabolism Magnesium metabolism
Magnesium metabolism
 
Special senses physiology revison topics
Special senses physiology revison topics Special senses physiology revison topics
Special senses physiology revison topics
 
CSF PHYSIOLOGY ANALYSIS NORMAL AND DISEASE
CSF PHYSIOLOGY ANALYSIS NORMAL AND DISEASE CSF PHYSIOLOGY ANALYSIS NORMAL AND DISEASE
CSF PHYSIOLOGY ANALYSIS NORMAL AND DISEASE
 
Plantar reflex
Plantar reflexPlantar reflex
Plantar reflex
 
Dna viruses
Dna virusesDna viruses
Dna viruses
 
Deep neck space infection ENT REVISION NOTES
Deep neck space infection ENT REVISION NOTES Deep neck space infection ENT REVISION NOTES
Deep neck space infection ENT REVISION NOTES
 
Antirheumatic drugs &amp; anti gout drugs PHARMACOLOGY REVISION NOTES
Antirheumatic drugs &amp; anti gout drugs PHARMACOLOGY REVISION NOTES Antirheumatic drugs &amp; anti gout drugs PHARMACOLOGY REVISION NOTES
Antirheumatic drugs &amp; anti gout drugs PHARMACOLOGY REVISION NOTES
 
Trauma to eye REVISION NOTES
Trauma to eye REVISION NOTES Trauma to eye REVISION NOTES
Trauma to eye REVISION NOTES
 
Orbit OPHTHALMOLOGY REVISION NOTES
Orbit OPHTHALMOLOGY REVISION NOTES Orbit OPHTHALMOLOGY REVISION NOTES
Orbit OPHTHALMOLOGY REVISION NOTES
 
Vision 2020 REVISION NOTES
Vision 2020 REVISION NOTES Vision 2020 REVISION NOTES
Vision 2020 REVISION NOTES
 
Cataract revisionnotes ophthalmology
Cataract revisionnotes ophthalmology  Cataract revisionnotes ophthalmology
Cataract revisionnotes ophthalmology
 
Uvea ophthalmology revision notes
Uvea ophthalmology revision notesUvea ophthalmology revision notes
Uvea ophthalmology revision notes
 
Genetics pathology revision notes
Genetics pathology revision notes Genetics pathology revision notes
Genetics pathology revision notes
 
Cell injury pathology revision notes
Cell injury pathology revision notes Cell injury pathology revision notes
Cell injury pathology revision notes
 
Morphology of bacteria revision notes microbiology
Morphology of bacteria revision notes microbiologyMorphology of bacteria revision notes microbiology
Morphology of bacteria revision notes microbiology
 

Recently uploaded

Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 

Recently uploaded (20)

Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 

Glomerular disorders OF KIDNEY REVISION NOTES

  • 6. 3 layers of glomerular membrane • Fenestrated endothelium • GBM • Foot process of podocytes TONY SCARIA 2010 KMC
  • 7. • Endothelial pore size 70-100nm • Filtration slit  TONY SCARIA 2010 KMC
  • 11. Size of particle >8nm cannot pass through GBM <4nm easily filtered irrespective of charge 4-8nm • Negatively charged particles are repelled TONY SCARIA 2010 KMC
  • 12. Endothelium • Negative charge is d/t podocalyxin • Fenestrated endothelium • Pore size 70-100nm TONY SCARIA 2010 KMC
  • 13. GBM • Glomerular basement membranee • Thickness  350-400nm • Thin basement membrane  <200nm • Type IV collagen • α3 α4 α5 • Electronegativity of GBM Heparin sulphate proteoglycans  perlecan & agrin TONY SCARIA 2010 KMC
  • 16. • GBM lined inside by • Endothelium & mesangium • Outside GBM lined by • Podocytes TONY SCARIA 2010 KMC
  • 17. Jones methylamine silver stain  best stain for GBM PAS also may be used to stain GBM TONY SCARIA 2010 KMC
  • 19. • Podocytes are terminally differentiated  cannot replicate or regenerate • Filtration • b/w 2 podocytes • 20-30nm • Electronegativity is d/t podocalyxin (sialoglycoprotein) TONY SCARIA 2010 KMC
  • 22. Mesangium • Foot process of mesangial cells contain actin microfilaments • Mesangial cell help in contraction TONY SCARIA 2010 KMC
  • 25. JGA • Mesangial cells • Macula densa of distal tubule • Granular cells of afferent arteriole secrete renin TONY SCARIA 2010 KMC
  • 29. Renin secretion is increased by Renin secretion is decreased by • Decreased intravascular volume • Decreased renal perfusion pressure • Sympathetic stimulation • PGE2 & PGI2 TONY SCARIA 2010 KMC
  • 30. • Endothelial injury microscopic hematuria • In post infectious GN • Injury to GBM  microscopic hematuria + proteinuria • Alport syndrome • Injury to mesangial cells  macroscopic hematuria • IgA nephropathy • Injury to podocyte  proteinuria • Membranous ds • FSGS • Minimal change ds TONY SCARIA 2010 KMC
  • 32. Asymptomatic Macroscopic hematuria Nephrotis syndrome • Asymptomati c • Proteinuria • Microscopic Hematuria • Proteinuria (>3.5gm/24h r) • Hypoalbumin emia • Edema • Hypercholest rolemia • Lipiduria Renal biopsy is required Renal biopsy is required FSGS Membranous nephropathy IgA nephropathy TONY SCARIA 2010 KMC
  • 34. Proteinuria types • Overflow proteinuria Tubular proteinuria Glomerular proteinuria Functional Orthostatic Persistent non nephrotic In multiple myeloma • Anxiety • Stress Overcomes ability of proximal tubule to reabsorb light chains • <2g/day • Mostly beta 2 macroglobulin is lost • >2g/day • Mostly albumin is lost • Loss of protein 150-500mg • Proteinurial alone in standing position • <1g/day • No proteinuria in lying down position  early morning sample –ve TONY SCARIA 2010 KMC
  • 37. Nephrotic syndrome • Characterised by • Albuminuria(proteinuria) • Hypoalbuminemia • Edema • Hyperlipidemia • lipiduria. • Hypercoagulability TONY SCARIA 2010 KMC
  • 38. Protein decreased Effect Albumin Edema Transferrin Iron resistant microcytic hypochromic anemia Thyroxine binding globulin Decreased thyroxine level Cholecalciferol binding protein Hypocalcemia Ceruloplasmin AT III Increased thrombus formation Nephrotic syndrome is characteristically associated with increased fibrinogen levels (Hyper fibrinogenemia)d/t increased hepatic synthesisTONY SCARIA 2010 KMC
  • 39. muerhrckes line in hypoalbuminemia TONY SCARIA 2010 KMC
  • 41. Causes of NS Systemic causes Glomerular disease • Diabetes mellitus (most common cause), SLE, Amyloidosis • Drugs: Gold, penicillamine probenecid , street heroin, captopril, NSAIDs • Infections: Bacterial endocarditis , hepatitis B , shunt infections, syphilis, malaria • Malignancy: Hodgkin’s and other lymphomas leukemia, carcinoma of breast and GI tract • Allergic reactions • 1. Minimal change disease (90% in children and 15% in adults) • 2. Membranous (40% in adults) • 3. Focal segmental glomerulosclerosis • 4. Membranoproliferative GN TONY SCARIA 2010 KMC
  • 44. Mc cause of nephrotic syndrome In children Minimal change disease In adults focal segmental glomerulosclerosis (FSGS) In old age Membranous GN Over all MC cause FSGS TONY SCARIA 2010 KMC
  • 45. Minimal change ds • Lipoid nephrosis • Most common cause of NS in children (2-7yrs) • Selective proteinuria of albumin  frothy urine • Edema • Hypertension not a feature TONY SCARIA 2010 KMC
  • 46. Causes of minimal change ds • Idiopathic • Drugs – NSAID, rifampicin, IFN – alpha • Malignancies  Hodgkin’s disease • HIV • Routine immunisation • Respiratory infection • Atopic disorders • Allergy • insect sting TONY SCARIA 2010 KMC
  • 49. MINIMAL CHANGE DS • No abnormality on electron microscopy • Elctron microscopy  obliteration & fusion of foot process • Immunofluroscopy no immune deposits • Serum compliment –> normal level TONY SCARIA 2010 KMC
  • 51. • Clinical Features- • Patient usually presents with insidious onset of generalized edema, without a decrease in urine output. • Patient may complain of passing frothy urine due to presence of protein. • Nephrotic syndrome is associated with = ↑LDL, ↑Tg, ↓HDL • Patient of nephrotic syndrome can develop spontaneous peripheral arterial or venous thrombosis • Increased susceptibility to infection •  MC cause is streptococcus pneumoniae followed by E coli TONY SCARIA 2010 KMC
  • 52. Minimal change ds not associated with • HTN • Microhematuria • AKI TONY SCARIA 2010 KMC
  • 53. Proteinuria in GN • Effacement of foot process (Earlier called fusion of foot process) is believed to play an important role in causes proteinuria in MCD. • Proteinuria occur due to. • 1. Loss of negative charge (Loss of polyanions) • 2. Disruption of components of slit diaphragm (Demonstrated in congenital nephrotic syndrome of the Finnish type) • 3. Loss of actin cytoskeleton TONY SCARIA 2010 KMC
  • 54. Urine in NS • Lipoid cast (d/t lipiduria) • Hyaline cast • NO RBC • Mlatese cross appearance  lipiduria TONY SCARIA 2010 KMC
  • 55. Hypercoagulability in NS • Spontaneous thrombosis of limb arteries • Renal vein thrombosis TONY SCARIA 2010 KMC
  • 56. Renal vein thrombosis in NS • More common in membranous nephropathy • Present with abdominal pain & haematuria • Renal vein thrombosis due to • 1. Increase Fibrinogen • 2. Increase Lipoproteins • 3. Reduced antithrombin III &protein C TONY SCARIA 2010 KMC
  • 57. Renal vein thrombosis • Trauma • Extrinsic compression (lymph nodes, aortic aneurysm, tumor) • Invasion by renal cell carcinoma • Dehydration (infants) • Nephrotic syndrome specially membranous GN (adults) • Pregnancy or oral contraceptives TONY SCARIA 2010 KMC
  • 58. • Common Renal pathologies causing Renal Vein Thrombosis • Membranous Glomerulonephritis (strongest association) • Membranoproliferative Glomerulonephritis • Amyloidosis • Lupus Nephritis TONY SCARIA 2010 KMC
  • 59. Congenital NS • With in first 3 months • Steroid resistant TONY SCARIA 2010 KMC
  • 60. Congenital NS Gene Protein Disease Inheritance NPHS1 Nephrin in slit diaphragm Nephrotic syndrome of finnish type (FSGS) AR inheritance 19p13.1 NPHS2 Podocin in slit diaphragm Steroid resistant NS(FSGS) AR 1q25 FSGS1 α actinin 4 FSGS Dominant 19p13 TONY SCARIA 2010 KMC
  • 61. Complications of NS • Infections (pneumococcal peritonitis) MC complication • Hypercholesterolemia (atherosclerosis, xanthomata) • 'The lipid profile in Nephrotic syndrome is characterized by elevations in total plasma cholesterol, VLDL and LDL and often (increases in later stages) triglyceride & reduced HDL. • Venous thrombosis and pulmonary embolism (urinary loss of antithrombin III, low plasma volume, increased Fibrinogen) • Hypovolemia and renal failure • Loss of specific binding proteins, e.g. transferrin, thyroid binding globulin.TONY SCARIA 2010 KMC
  • 62. Indications for renal biopy in NS • To r/o causes other than MCNS • Age <1yr or > 8 yrs • Adult is less likely to be MCNS  mandatory renal biopsy • Gross hematuria • HTn • Renal insufficiency • Low C3 • Initial steroid resistance TONY SCARIA 2010 KMC
  • 63. Rx • Salt restriction < 2g/day • Protein  1g/kg/day • Target BP TONY SCARIA 2010 KMC
  • 66. Minimal change ds progressing to AKI • Generally no features of AKI • But can occur if • Severe hypoalbuminemia pre renal failure • RVT TONY SCARIA 2010 KMC
  • 67. Membranous GN • MC of NS in elderly TONY SCARIA 2010 KMC
  • 68. Membranous GN • It is characterized morphologically by the presence of subepithelial immunoglobulin-containing deposits along the GBM. • Early in the disease, the glomeruli may appear normal by light microscopy, but well-developed cases show diffuse thickening of the capillary wall TONY SCARIA 2010 KMC
  • 70. Diffuse granular staining of basement membrane with Ig & complement TONY SCARIA 2010 KMC
  • 72. Electron microscopy • Subepithelial GBM deposits • Eoimembranous deposits • Deposition of immune complexes b/w BM & podocytes • effacement of podocytes TONY SCARIA 2010 KMC
  • 74. Pathogenesis of membranous GN Primary membranous GN Secondary membranous GN autoantibodies that cross-react with antigens expressed by podocytes Secondary to other systemic ds Rat model Human model Ab against megalin Ag of rat podocyte  heymann nephritis Ab against PLA2 receptor of human podocyte TONY SCARIA 2010 KMC
  • 76. Causes of secondary GN Idiopathic (majority) infection: Neoplasia Drugs: Miscellaneous Autoimmunse ds • Hepatitis B and C • secondary and congenital syphilis • malaria, • schistosomiasis, • leprosy, • hydatid disease, • filariasis, • enterococcal endocarditis • Carcinoma of the breast, lung, colon, stomach, and esophagus; • melanoma; • renal cell carcinoma; • neuroblastoma; • carotid body tumor • Gold, • penicillamine, • captopril, • NSAIDs, • probenecid, • trimethadione, • chlormethiazole, • mercury 1. ​Sarcoidosis 2. Diabetes mellitus 3. Sickle cell disease 4. Crohn’s disease 5. Guillain – Barre syndrome • SLE, • rheumatoid disease, • Sjorgren’s syndrome, Hashimoto’s disease,Graves’ disease, mixed connective tissue disease, primary biliary cirrhosis, • ankylosing spondylitis, • dermatitis herpetiformis, bullous pemphigoid, • myasthenia gravis TONY SCARIA 2010 KMC
  • 77. CF of membranous GN • Massive proteinuria • Hematuria & HTn in 15-35 % cases • Patients present with edema, nephrotic proteinuria and high BP. • Renal insufficiency and abnormal urine sediment may develop later. • Renal vein thrombosis is common. TONY SCARIA 2010 KMC
  • 79. Focal segmental glomerulosclerosis • MC overall cause of NS • MC in adults TONY SCARIA 2010 KMC
  • 80. FSGS • sclerosis affecting some but not all glomeruli (focal involvement) and involving only segments of each affected glomerulus (segmental involvement) TONY SCARIA 2010 KMC
  • 82. Focal & segmental involvement of glomeruli in FSGS TONY SCARIA 2010 KMC
  • 83. Pathogenesis of FSGS • injury to the podocytes initiating event of primary FSGS • Lymphocyte produced factor increasing permeability • The deposition of hyaline masses in the glomeruli represents the entrapment of plasma proteins and lipids in foci of injury where sclerosis develops. • IgM and complement proteins commonly seen in the lesion are also believed to result from nonspecifc entrapment in damaged glomeruli TONY SCARIA 2010 KMC
  • 84. Causes of FSGS • Idiopathic (majority) • In associated with systemic diseases or drugs: • 1. HIV infection • 2. Diabetes mellitus • As consequence of sustained glomerular capillary hypertension • Congenital oligo nephropathies • Unilateral renal agenesis • Reflux nephropathy • Glomerulonephritis or tubulointerstitial nephritis • Sickle cell nephropathy • Heroin use • Congenital Nephrotic syndrome • NPH1 • NPH2 • FSGS1  autosomal dominant FSGS • Mutation in TRPC6 TONY SCARIA 2010 KMC
  • 85. Mutated TRPC6  adult onset type FSGS (increasing Ca2+ influx) TONY SCARIA 2010 KMC
  • 86. APOL1 gene mutation in FSGS • apolipoprotein L1 gene (APOL1) on chromosome 22 appears to be strongly associated with an increased risk of FSGS and renal failure TONY SCARIA 2010 KMC
  • 87. Histologic variants of FSGS Collapsing variant • Worse prognosis Glomerular tip variant • Best prognosis Perihilar variant Cellular variant TONY SCARIA 2010 KMC
  • 88. Variants of FSGS TONY SCARIA 2010 KMC
  • 89. • Light microscopy • increased mesangial matrix, obliterated capillary lumina, and deposition of hyaline masses (hyalinosis) and lipid droplets. • Electron microscopy • podocytes exhibit effacement of foot processes, as in minimal change disease • IF • Nonspecific trapping of Ig (especially IgM) & complement(C3) TONY SCARIA 2010 KMC
  • 90. Collapsing variant of FSGS • Worst prognosis • It is characterized by collapse of the glomerular tuft and podocyte hyperplasia • associated with HIV infection, drug-induced toxicities, and some microvascular injuries TONY SCARIA 2010 KMC
  • 91. • CF: • Proteinuria is present and is usually nonselective. • Hypertension, reduced GFR(arteriolar obliteration by sclerosis), abnormal tubular function and abnormal urinary sediments (leukocyturia, hematuria) are seen. • Hyperlipidemia is severe in cases with focal sclerosis. TONY SCARIA 2010 KMC
  • 92. Relfux nephropathy & FSGS • FSGS may develop following acquired loss of nephrons from reflux nephropathy • Association of reflux nephropathy and proteinuria suggest an irreversible glomerular lesion most commonly FSGS TONY SCARIA 2010 KMC
  • 93. Podocytopathies • a/w podocyte injury • Minimal change ds • Membranous GN • FSGS TONY SCARIA 2010 KMC
  • 94. Membranoproliferative GN • Immune mediated injury TONY SCARIA 2010 KMC
  • 97. Type 1 (MC SUBTYPE) Type II Type III Sub endothelial electron dense deposits lamina densa and the subendothelial space of the GBM are transformed into an irregular, ribbon- like, extremely electron-dense structure, resulting from the deposition of material of unknown composition DENSE DEPOSIT DISEASE Double contours of GBM & subendothelial deposits subepithelial deposits Subendothelial deposits of occasionally granular epithelial & mesangial Ig Intramembranous deposition Activation of classical & alternate pathway Activation of alternate pathway • Idiopathic • Bacterial endocarditis • SLE • Hepatitis C • Mixed cryoglobulinemia • Hepatitis B • Cancer: Lung, breast, and ovary (germinal) • Idiopathic • C3 nephritic factor–associated • Partial lipodystrophy • Idiopathic • Complement FACTOR deficiency TONY SCARIA 2010 KMC
  • 99. Type I MPGN TONY SCARIA 2010 KMC
  • 100. Type I MPGN • discrete subendothelial electron-dense deposits • C3 is deposited in an irregular granular pattern, and IgG and early complement components (C1q and C4) often are also present, indicative of an immune complex pathogenesis TONY SCARIA 2010 KMC
  • 101. Type II MPGN TONY SCARIA 2010 KMC
  • 102. Type II MPGN • d/t activation of alternate complement pathway • They have C3 nephritic factor (C3NeF) • Stabilises C3 convertase  enhancing C3 activation  hypocomplementemia TONY SCARIA 2010 KMC
  • 103. Type III MPGN • Intramembranous + subendothelial + subepithelial deposit TONY SCARIA 2010 KMC
  • 105. Light microscopy • Thickened capillary loops • Glomerular cell proliferation • Lobular appearance of glomeruli • d/t mesngial proliferation • Duplication of basement membrane TONY SCARIA 2010 KMC
  • 110. • Compliment levels are normal in • 1. Minimal change GN • 2. Membranous GN • 3. FSGS Decreased compliment level in MPGN TONY SCARIA 2010 KMC
  • 112. Nephritic syndrome • a/c glomerulonephritis • Hypertension, • Hematuria with red cell cast  high coloured urine • non nephrotic Proteinuria • Normal albumin level • Azotemia & Oliguria a/w AKI • RBC cast are present in the urine. TONY SCARIA 2010 KMC
  • 113. nephritic syndromw Mc cause in Children Post streptococcal GN Adults IgA nephropathy Overall IgA nephropathy TONY SCARIA 2010 KMC
  • 116. a/c proliferative GN Post infectious GN TONY SCARIA 2010 KMC
  • 117. • Postinfectious glomerulonephritis • occur as a sequela of disease caused by bacteria, viruses, fungi, protozoa, and helminths • Post streptococcal GN most common cause of GN in childhood TONY SCARIA 2010 KMC
  • 118. Nephritis develops 1–3 weeks after pharyngeal (more common in winter) or cutaneous infection with (more common in summer) ‘nephritogenic’ strains of group A beta – hemolytic streptococci Group A beta haemolytic streptococci TONY SCARIA 2010 KMC
  • 120. Pathogenesis of PSGN • immune complex disease TONY SCARIA 2010 KMC
  • 125. • Light microscopy • diffuse  increased cellularity of the glomerular tufts that affects nearly all glomeruli • Electron microscopy • deposited immune complexes arrayed as subendothelial, intramembranous, or, most often, subepithelial “humps” nestled against the GBM • Immunofluorescence studies reveal scattered granular deposits of IgG and complement within the capillary walls and some mesangial areas, corresponding to the deposits visualized by electron microscopy. TONY SCARIA 2010 KMC
  • 128. IF deposits  starry sky appaearance in PSGN TONY SCARIA 2010 KMC
  • 129. CF of PSGN • sudden onset of hematuria and edema TONY SCARIA 2010 KMC
  • 130. Lab findings • Hypocomplementemia • elevated titers of • antistreptolysin 0, • antihyaluronidase, and • anti-deoxyribonuclease B antibodies • Unfavourable prognostic factors • Prolonged persistent heavy proteinuria • Abnormal GFR TONY SCARIA 2010 KMC
  • 131. Rx • Hypertension must be treated aggressively, • Furosemide or bumetanide is required for the underlying edema- inducing disease. • Antibiotic - penicillin. • Prophylaxis following poststreptococcal glomerulonephritis is not indicated because recurrences are exceedingly rare. • Early treatment of pharyngitis does not prevent development of acute GN. • Immunosuppressive agents or corticosteroids have no therapeutic role. • Recurrence is uncommon with PSGNTONY SCARIA 2010 KMC
  • 132. IgA Nephropathy (Berger’s Disease) • Most common causes of recurrent microscopic or gross hematuria • MC of GN world wide • IgA nephropathy is a type of mesangioproliferative glomerulonephritis with IgA deposition in the mesangium • Pathogenesis • Genetic or acquired defects in immune regulation • Increased IgA1 secretion (only IgA1 is nephritogenic) • Decreased clearance of IgA TONY SCARIA 2010 KMC
  • 133. Onset of hematuria occurs 1-4 days after URTI TONY SCARIA 2010 KMC
  • 134. Secondary IgA nephropathy • Celiac ds • c/c Liver pathology • HSP TONY SCARIA 2010 KMC
  • 135. • Light microscopy • Mesangial proliferation • Cresents may be present • Electron microscopy • Mesangial deposits of IgA IgG or IgM with C3 • Compliment level remain same TONY SCARIA 2010 KMC
  • 138. IgA nephropathy PSGN Onset of hematuria after URTI 1-4 days 1-4 weeks Serum C3 level Normal Transiently decreases for 6-8 weeks Recurrence Common Rare Antibody titre Not elevated Elevated ASO titre TONY SCARIA 2010 KMC
  • 139. Other causes of mesangioproliferative GN Mesnagioproliferative GN • IgA nephropathy • HSP Proliferation of mesangial cells and deposition of IgA in matrix • Hematuria • Proteinuria • Hypertension TONY SCARIA 2010 KMC
  • 141. RPGN • RPGN is defined by 2 criteria • 1. Presence of epithelial crescents in more than 70% of glomeruli • 2. Occurrence of rapidly progressive renal failure, End stage disease occurs within month • Presents with nephritic syndrome  rapidly progresses to loss of renal function TONY SCARIA 2010 KMC
  • 145. Crescents are features of RPGN • Crescents are made up of proliferated parietal epithelial cells fibrin & leucocyte TONY SCARIA 2010 KMC
  • 147. Type I RPGN Type II RPGN Type III RPGN Anti GBM mediated Ab against α3 chain of collagen IV Immune complex mediated Pauci immune ANCA associated Most common IF  linear deposits along basement membrane IF granular deposits IF  no deposits TONY SCARIA 2010 KMC
  • 149. Type I RPGN Type II RPGN Type III RPGN • Idiopathic • Good pastures syndrome • Idiopathic • SLE • Ig A nephropathy • MPGN • Cryoglobulinemia • Post infectious GN • Idiopathic • Granulomatosis with polyangitis • Microscopic polyangitis • Best prognosis TONY SCARIA 2010 KMC
  • 150. Prognosis of RPGN • The prognosis of RPGN depends upon Number of crescents. TONY SCARIA 2010 KMC
  • 151. • Diagnosis • Renal biopsy • Rx • Plasmapheresis & immunosuppression • In immune complex glomerulonephritis, treatment depends on the individual causative disorder. • In pauci-immune deposit disease, treatment involves pulse methylprednisolone and cyclophosphamide. TONY SCARIA 2010 KMC
  • 152. Good pasture syndrome TONY SCARIA 2010 KMC
  • 153. Good pasture syndrome • characterized by formation of Anti GBM antibodies that attack both pulmonary capillaries and the Glomerulus • Type II hypersensitivity TONY SCARIA 2010 KMC
  • 154. Triad of goodpasture syndrome • Anti GBM ab • Directed against Non collagenous domain of type α3 collagen • Glomerulonephritis (usually crescentic) • Pulmonary hemorrhage (Hemoptysis may precede nephritis). TONY SCARIA 2010 KMC
  • 157. Ab in good pasture syndrome • Circulating Anti GBM antibodies (lgG): Positive • ANCA antibodies: Typically Negative (ANCA negative vasculitis) • ANA antibodies: usually normal • C3 levels: Usually normal • Antibodies against Non collagenous Domain (NCL) of a3 chain of collagen type IV TONY SCARIA 2010 KMC
  • 158. CF in good pasture syndrome • 1. Hemoptysis (Frank) • 2. Dyspnea • 3. Hematuria • 4. Proteinuria • 5. Edema TONY SCARIA 2010 KMC
  • 159. Pathology in good pasture syndrome • Diffuse crescentic Glomerulonephritis • Linear IgG staining along basement membrane on immunofluorescence TONY SCARIA 2010 KMC
  • 160. B/L pulmonary infiltrates are seen on CXR in good pasture syndrome TONY SCARIA 2010 KMC
  • 161. • Treatment: • 1. Plasma exchange may produce remission. • 2. Prednisolone • 3. Immunosuppressive therapy TONY SCARIA 2010 KMC
  • 166. Alport syndrome • X linked dominant form (85 % case) • Mutation in α chain • Autosomal forms • Mutation in α3 or α4 chain TONY SCARIA 2010 KMC
  • 167. Eye EAR Kidney • Anterior lenticonus Sensorineural deafness Hematuria Proteinuria Abnormal splitting & lamination of basement membrane TONY SCARIA 2010 KMC
  • 168. ANTERIOR LENTICONUS IN ALPORT SYNDROME TONY SCARIA 2010 KMC
  • 170. GBM splitting & lamination  basket weave appearance TONY SCARIA 2010 KMC
  • 172. Thin basement membrane ds • Benign familial hematuria • Asymptomatic hematuria • Thickness of GBM <200nm TONY SCARIA 2010 KMC
  • 175. HSP • MC vasculitis of childhood • Characterised by leukocytoclastic vasculitis & IgA deposition in small vessels of skin joints GIT & kidney • Renal involvement hematuria and proteinuria. • Serum IgA is normal or raised, platelet count is normal. TONY SCARIA 2010 KMC
  • 176. LAB DIAGNOSIS OF HSP • Antinuclear antibody (ANA) Negative • Antineutrophil cytoplasmic Negative • Antibodies (ANCA) Negative • Complement (C3, C4) Normal • Cryoglobulins Negative TONY SCARIA 2010 KMC
  • 177. CF • Palpable purpura • Symmetric mainly on lower extremities & buttocks • Oligoarticular arthritis & arthralgia • GI manifestation • Abdominal pain malena diaarhea • Renal involvement • Microscopic hematuria (nephritis) • Proteinuria • HTn • Neurologic • Seizures • Cerebral haemorrhage • TONY SCARIA 2010 KMC
  • 179. American college of rheumatology Pediatric rheumatology European society criteria 2 of the following  Palpable purpura  Age at onset <20 yr  Bowel angina (post prandial abdominal pain/ bloody diarrhea)  Biopsy  demonstrating intramuscular granulocytes in arterioles or venules Palpable purpura (in absence of coagulopathy or thrombocytopenia  Abdominal pain  Arthritis or arthralgia  Biopsy  IgA deposition  Renal involvement • Proteinuria • Hematuria • Red cell cast TONY SCARIA 2010 KMC
  • 182. Diagnosis • Leukocytosis thrombocytosis anemia normal platelet count • Elevated ESR & CRP • Serum IgA elevated • Serum albumin levels may be low • Occult blood TONY SCARIA 2010 KMC
  • 183. Rx of HSP • Supportive Rx • Prednisolone 1mg/kg/day for 1-2 weeks TONY SCARIA 2010 KMC
  • 186. c/c glomerulonephritis • poststreptococcal (1% to 2%);  least common chance of progression • rapidly progressive (crescentic) (90%) most common chance of progression • membranous (30% to 50%), • focal segmental glomerulosclerosis (50% to 80%), • membranoproliferative GN (50%), • IgA nephropathy (IgAN, 30% to 50%). TONY SCARIA 2010 KMC
  • 187. c/c glomerulonephritis the cortex is thinned increase in peripelvic fat TONY SCARIA 2010 KMC
  • 188. c/c glomerulonephritis • arterial and arteriolar sclerosis • Marked atrophy of associated tubules, irregular interstitial fibrosis, and mononuclear leukocytic infiltration of the interstitium • obliteration of glomeruli, transforming them into acellular eosinophilic masses, TONY SCARIA 2010 KMC
  • 189. Systemic diseases a/w renal ds TONY SCARIA 2010 KMC
  • 190. Diabetic nephropathy • Most important predictor of diabetic nephropathy is duration of disease • 20 yrs prediction of nephropathy • Type 1  30 -40 % • Type 2 15-20 % TONY SCARIA 2010 KMC
  • 191. Mechanism of diabetic nephropathy • Nonenzymatic glycosylation of proteins of basement membrane TONY SCARIA 2010 KMC
  • 192. • Earliest lab finding in diabetic nephropathy  increase in GFR • early stages of diabetic nephropathy are characterized by an increased GFR, increased glomerular capillary pressure, glomerular hypertrophy, and an increased glomerular filtration area TONY SCARIA 2010 KMC
  • 193. Lesions seen in diabetic nephropathy glomerular lesions renal vascular lesions, principally arteriolosclerosis pyelonephritis, including necrotizing papillitis • capillary basement membrane thickening (earliest lesion) • diffuse mesangial sclerosis(most common histologic finding) • nodular glomerulosclerosis TONY SCARIA 2010 KMC
  • 194. Glomerular lesions Capillary basement membrane thickening Diffuse glomerulosclerosis Nodular glomerulosclerosis • Earliest lesion • diffuse increase in mesangial matrix along with mesangial cell proliferation and • Glomerular lesion made distinctive by ball-like deposits of a laminated matrix situated in the periphery of the glomerulus TONY SCARIA 2010 KMC
  • 196. Nodular glomerulosclerosis • Most specific & pathognomonic TONY SCARIA 2010 KMC
  • 197. Fibrin cap & capsular drop in diabetic retinopathy TONY SCARIA 2010 KMC
  • 198. Hyaline arteriolar sclerosis • Affecting afferent & efferent arteriole TONY SCARIA 2010 KMC
  • 199. Armanni ebstein cells • In poorly controlled diabetics • Proximal tubular cells filled glycogen laden vacuole TONY SCARIA 2010 KMC
  • 200. Causes of papillary necrosis TONY SCARIA 2010 KMC
  • 202. Papillary necrosis • DM  commonest cause • Analgesic nephropathy • Sickle cell anemia • c/c alcoholism • Urinary tract obstruction • a/c pyelonephritis TONY SCARIA 2010 KMC
  • 206. • Ball-on-tee appearance: Contrast material filling central excavations in the papilla of the interpolar region gives ball-on-tee appearance. • Lobster claw sign: Excavation extending from the caliceal fornices produces the lobster claw deformity. • Signet ring sign: The necrotic papillary tip may remain within the excavated calyx, producing the signet ring sign when the calyx is filled with contrast material. • Club shaped saccular calyx: Due to sloughed papillaTONY SCARIA 2010 KMC
  • 208. Hepatitis C • Cryoglobulinemic glomerulonephritis • Membranous glomerulonephritis (MGN) • Membrano prolferative glomerulo nephritis(MPGN) Hepatitis B • In children  MGN • In adults  MPGN • Over all  MGN Toxoplasmosis • MPGN Syphilis Schistosomiasis • MGN Leprosy • Secondary amyloidosis • Mesangiocapilalry GN • MPGN1 • Membranous GN Malaria • Plasmodium malaria  NS • Plasmodium falciparum  renal failure TONY SCARIA 2010 KMC
  • 209. Essential mixed cryoglobulinemia • Cold precipitable monoclonal or polyclonal immunoglobulins • It causes cutaneous vasculitis synovitis palpable purpura • It causes proliferative GN most commonly MPGN type 1 • a/w hepatitis C • Hypocomplimentinemia TONY SCARIA 2010 KMC
  • 210. Fibronectin nephropathy • Autosomal dominant • d/t accumaltion of plasma fibronectin • Presents with Massive proteinuria TONY SCARIA 2010 KMC
  • 212. Morphology • Light microscopy • Glomerular enlargement & lobulation d/t mesangial proliferation & mesangial deposits • PAS & trichrome positive • Renal tubules interstitium blood vessels are not affected • Immunofurescence • No immunoglobulin & compliment deposits are seen • Electron microscopy • Mesangial & subendothelial deposits TONY SCARIA 2010 KMC